Abstract:Sonodynamic therapy (SDT) is a physical therapy that utilizes critical sonosensitizers triggered by ultrasound to achieve an effective non-invasive tumor treatment. However, the inadequate sonodynamic efficacy and low responsive activities of traditional inorganic sonosensitizers have hindered its practical application. Here, we rationally design a platinum-zinc oxide (PtZnO) sonosensitizer to significantly enhance the efficacy of SDT through its inherent bandgap structure and dual-nanozyme activities. The PtZnO possesses a narrow bandgap (2.89 eV) and an appropriate amount of oxygen defects, which promote the efficiency of electrons and holes separation and the generation of reactive oxygen species (ROS) under US irradiation. Simultaneously, the PtZnO exhibits both catalase-like and peroxidase-like activities, which effectively catalyze endogenous H2O2 into a large number of O2 and toxic hydroxyl radicals (•OH), thus achieving an efficient enhancement of SDT and catalytic therapy. Moreover, the PtZnO has significant glutathione consumption performance, further amplifying the oxidative stress. Ultimately, the PtZnO achieves a triple ROS amplification effect, with the yields of singlet oxygen (1O2) and •OH reaching 859.1 % and 614.4 %, respectively, inducing a highly effective sono-catalytic therapy with a remarkable tumor inhibition rate of 98.1 %. This study expands the application of ZnO semiconductor heterojunctions in the nanomedicine area, and the simple yet efficient design of the PtZnO provides a strategy for the development of sonosensitizers. STATEMENT OF SIGNIFICANCE: A platinum-zinc oxide (PtZnO) heterojunction sonosensitizer is constructed with dual-nanozyme activities and achieves a triple ROS amplification effect, leading to an efficient synergistic sono-catalytic therapy. The PtZnO owns an inherent narrow bandgap and abundant oxygen defects, thus exhibiting an efficient sonosensitizer performance. It also possesses both catalase-like and peroxidase-like activities, which effectively catalyze the endogenous H2O2 into a large quantity of O2 and toxic hydroxyl radicals, thereby enhancing the SDT and catalytic therapy. Furthermore, its prominent glutathione consumption performance further amplifies oxidative stress. The yields of singlet oxygen and hydroxyl radicals reach up to 859.1 % and 614.4 %, respectively, inducing a highly effective sono-catalytic therapy with an impressive tumor inhibition rate of 98.1 %.

Ultrasound-Activatable G-C3 N4 -Anchored Titania Heterojunction As an Intracellular Redox Homeostasis Perturbator for Augmented Oncotherapy.

Tumor Metabolism‐Engineered Composite Nanoplatforms Potentiate Sonodynamic Therapy Via Reshaping Tumor Microenvironment and Facilitating Electron–Hole Pairs’ Separation

Platinum-Titania Schottky Junction As Nanosonosensitizer, Glucose Scavenger, and Tumor Microenvironment-Modulator for Promoted Cancer Treatment

Nitrogen Vacancy-Rich Carbon Nitride Anchored with Iron Atoms for Efficient Redox Dyshomeostasis under Ultrasound Actuation

Engineering Janus Chemoreactive Nanosonosensitizers for Bilaterally Augmented Sonodynamic and Chemodynamic Cancer Nanotherapy

Redox Imbalance Triggered Intratumoral Cascade Reaction for Tumor “turn On” Imaging and Synergistic Therapy

Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem

Interfacial engineering of Ti3C2-TiO2 MXenes by managing surface oxidation behavior for enhanced sonodynamic therapy

A Novel Reactive Oxygen Species Nano-Amplifier for Tumor-Targeted Photoacoustic Imaging and Synergistic Therapy

Defect-rich platinum-zinc oxide heterojunction as a potent ROS amplifier for synergistic sono-catalytic therapy

A MXene-derived redox homeostasis regulator perturbs the Nrf2 antioxidant program for reinforced sonodynamic therapy

Interference with Redox Homeostasis Through a G6PD-Targeting Self-Assembled Hydrogel for the Enhancement of Sonodynamic Therapy in Breast Cancer.

In-situ TiO2-x decoration of titanium carbide MXene for photo/sono-responsive antitumor theranostics

TiO2 Nanosheets with the Au Nanocrystal-Decorated Edge for Mitochondria-Targeting Enhanced Sonodynamic Therapy

Zirconia-Platinum Nanohybrids for Ultrasound-Activated Sonodynamic-Thermodynamic Bimodal Therapy by Inducing Intense Intracellular Oxidative Stress

Biomimetic redox-responsive prodrug micelles with diselenide linkage for platinum nanozymes augmented sonodynamic/chemo combined therapy of colon cancer

A Sonication-Activated Valence-Variable Sono-Sensitizer/Catalyst for Autography Inhibition/Ferroptosis-Induced Tumor Nanotherapy

Tumor Microenvironment‐Responsive Cu/CaCO3‐Based Nanoregulator for Mitochondrial Homeostasis Disruption‐Enhanced Chemodynamic/Sonodynamic Therapy

Two-Dimensional MXene-Originated in Situ Nanosonosensitizer Generation for Augmented and Synergistic Sonodynamic Tumor Nanotherapy.

Ultrasound cascade regulation of nano-oxygen hybrids triggering ferroptosis augmented sonodynamic anticancer therapy

Biomimetic nanoplatform with H2O2 homeostasis disruption and oxidative stress amplification for enhanced chemodynamic therapy